Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

The Clinical Trials Market report delivers crucial insights into the ... this report acts as a strategic tool for organizations striving to meet their business goals. Phase I studies usually test new ...

accounted for 18% of the total sample size in the Phase 2 study. A consistent top-enroller in acute schizophrenia clinical trials, Segal Trials contributed to the study sample size with a rate of ...

The UK experienced a notable increase in advanced therapy clinical trials in 2024, reaching 187 ongoing trials. This marks a 7% rise from the previous year. Particularly, phase I trials saw an ...

By Stephanie Nolen Stephanie Nolen has reported on U.S.A.I.D.-funded clinical trials in more than a dozen countries in Africa, Asia and Latin America. Feb. 6, 2025 Asanda Zondi received a ...

You're thinking of participating in a clinical trial – what now? Ask questions and weigh the risks before deciding if a clinical trial is right for you.

We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...

In September 2023, the FDA granted approval to bosutinib for use in children ages 1 year and older with chronic phase Philadelphia ... targeted therapy drug. Clinical trials are studies comparing ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

These guidelines were established under the Food and Drug Omnibus Reform Act of 2022, enacted by Congress to promote inclusivity in clinical trials. It’s upsetting to see. But I predict those ...

With the readout of UNVEIL-IT® Phase 2, which evaluates VS-01, also targeted in the second half of 2025, up to 4 clinical datasets are expected to be released by GENFIT before the end of this year ...